Teva Pharmaceuticals (Teva) has launched the first generic glucagon-like peptide-1 (GLP-1) drug for weight loss in adults and adolescents
Court Observation The Delhi High Court noted that the name closely resembled Novo Nordisks Ozempic, raising concerns about confusion among patients and healthcare professionals
At Everliv, we believe health is the greatest luxury
For the study, researchers tracked more than 24,700 type 2 diabetics newly prescribed GLP-1 drugs, comparing their health to that of more than 89,000 who were prescribed SGLT-2 inhibitors
(The more hardcore bodybuilders will opt for 1-2 IU of insulin with or instead of the carbohydrates to really ramp things up, but thats not going to be discussed in this article)
Sounds like a superpower, right